Aro Biotherapeutics has filed a notice of an exempt offering of securities to raise $100,000,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Aro Biotherapeutics is raising $100,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Susan Dillon played a key…